Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effectiveness and safety of risperidone in adolescents with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED